Merantix
Overview
Merantix transforms how businesses, healthcare organizations, and governments operate by building products that apply machine intelligence to their enterprise datasets. We acquire datasets that enable promising products, we incubate those products, and we spin off ventures to support their growth. We take advantage of three core competencies: Our experience applying machine learning, our expertise building enterprise partnerships to assemble vast datasets, and our culture of rapidly iterating to build scalable products. Our projects are meaningful and diverse. Currently we work on: - Automated medical image diagnosis - Financial models for automated trading on new markets - Deep neural networks used for autonomous driving
Investment Focus
- AI-native companies
- Early-stage startups
- European market focus
- Innovative applications of AI
- Scalable business models
- Multidisciplinary founding teams
- Societal impact orientation
Portfolio Companies
Reach Merantix directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Merantix
What sectors does Merantix invest in?
Merantix invests in Healthcare, Finance, Artificial Intelligence, Life Sciences, Manufacturing and Legal, and is based in Berlin, Berlin, Germany. Merantix is listed as a venture capital in the ConnectSafely investor database.
What stage does Merantix invest at?
Merantix backs companies at Pre-Seed and Seed, writing cheques of 500K - 4M.
Which regions does Merantix invest in?
Merantix invests across United States, United Kingdom, Germany, France, Italy and Denmark.
What companies has Merantix invested in?
Merantix's portfolio includes Deltia, Graph Therapeutics and Ficus Health.
Last updated · Source: ConnectSafely investor database
